A joint pre-submission advice and consultation procedure for EU manufacturers of companion diagnostics is needed as a growing matter of urgency, given that these products will be regulated Europe-wide for the first time under the forthcoming IVD Regulation.
Appropriate guidance on this should be developed as soon as possible by the European Medicines Agency (EMA), together with notified...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?